Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.8 USD | +2.20% | -2.78% | -12.56% |
May. 03 | Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $47 From $48, Keeps Neutral Rating | MT |
May. 02 | Transcript : Ultragenyx Pharmaceutical Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.56% | 3.4B | |
+4.67% | 109B | |
+11.58% | 105B | |
+0.79% | 22.25B | |
-11.76% | 22.09B | |
-7.75% | 18.68B | |
-38.36% | 17.58B | |
-9.65% | 16.85B | |
+4.93% | 13.76B | |
+37.17% | 12.46B |
- Stock Market
- Equities
- RARE Stock
- News Ultragenyx Pharmaceutical Inc.
- Insider Sell: Ultragenyx Pharmaceutical